BL
Bernard Lammek

Highly Cited

148
Works
1,909
Citations
21
H-Index
Search Authors
Author Statistics
  • OpenAlex ID A5105361172
  • i10-Index 45
  • 2-Yr Mean Citedness 0.00
External Links
OpenAlex Profile

Bernard Lammek

Also known as: B LAMMEK, B Lammek, B. LAMMEK, B. Lammek, B. Lammek A. Prahl

148

Total Works

1,909

Citations

21

H-Index

45

i10-Index

Citation & Works Trend by Year
54 years active
Top Research Topics
Chemical Synthesis and Analysis (114) Neuropeptides and Animal Physiology (82) Neuroendocrine regulation and behavior (42) Coagulation, Bradykinin, Polyphosphates, and Angioedema (27) Protein Structure and Dynamics (24)
Recent Publications
15 shown
Year Publication Title Citations Action
2013 Design, Synthesis, and Structure–Activity Relationship Studies of a Potent PACE4 Inhibitor Journal of Medicinal Chemistry 31
2013 Chemical Synthesis and Analysis of Short Peptides Containing Modified Arginine Residues American Peptide Symposium (APS) 0
2012 Design, Synthesis and Structure–Activity Relationship of New Arginine Vasopressin Analogues Containing Proline Derivatives in Position 2 Chemical Biology & Drug Design 4
2012 The Multi-Leu Peptide Inhibitor Discriminates Between PACE4 and Furin And Exhibits Antiproliferative Effects On Prostate Cancer Cells Journal of Medicinal Chemistry 49
2012 Novel Bradykinin Analogues Modified in the N-Terminal Part of the Molecule with a Variety of Acyl Substituents International Journal of Peptide Research and Therapeutics 4
2011 Design, synthesis and biological activity of new neurohypophyseal hormones analogues conformationally restricted in the N-terminal part of the molecule. Highly potent OT receptor antagonists Amino Acids 7
2011 [List gratulacyjny Rektora Uniwersytetu Gdańskiego z okazji 10. rocznicy powołania Uniwersytetu Zielonogórskiego] Digital library of Zielona Gora (University of Zielona Góra) 0
2011 Novel analogues of bradykinin conformationally restricted in the C‐terminal part of the molecule Journal of Peptide Science 1
2010 New Analogues of Arginine Vasopressin and Its Selected Agonists Modified at Position 2 with (S)-2-(1-Adamantyl)glycine ASEP 0
2009 Novel analogues of arginine vasopressin containing α‐2‐indanylglycine enantiomers in position 2 Journal of Peptide Science 7
2009 Analogues of arginine vasopressin modified at position 2 with proline derivatives: selective antagonists of oxytocin in vitro Advances in experimental medicine and biology 1
2009 Analogues of arginine vasopressin modified in the N-terminal part of the molecule with pipecolic acid isomers Advances in experimental medicine and biology 0
2008 Arginine vasopressin and its analogues – The influence of position 2 modification with 3,3-diphenylalanine enantiomers. Highly potent V2 agonists European Journal of Medicinal Chemistry 16
2008 Structure–activity relationships of novel peptide agonists of the human bradykinin B2 receptor Peptides 40
2008 Analogues of AVP modified in theN‐terminal part of the molecule with Pip isomers: TFA‐catalysed peptide bond hydrolysis Journal of Peptide Science 5

Data source: OpenAlex API